GlaxoSmithKline Ebola Vaccine Deemed "Acceptable" for Human Trials

By Gary Cutlack on at

An ebola vaccine that sailed through its phase 1 trials is ready for use in the real world according to the World Health Organisation, with a modified chimpanzee cold virus given the go-ahead for a six month test on humans.

Marie-Paule Kieny from the WHO says the GSK vaccine and one developed by Merck and NewLink are both ready for testing in West Africa, where healthy aid workers will be the first to be asked to volunteer to be vaccinated with the new potion. [AP via Ars]

Image credit: Ebola warning from Shutterstock